Cargando…
Patients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma
BACKGROUND: Although asthma does not appear to be a risk factor for severe coronavirus disease 2019 (COVID-19), outcomes could vary for patients with different asthma subtypes. The objective of this analysis was to compare COVID-19 outcomes in real-world cohorts in the United States among patients w...
Autores principales: | Murphy, Thomas R., Busse, William, Holweg, Cecile T. J., Rajput, Yamina, Raimundo, Karina, Meyer, Craig S., Seetasith, Arpamas, Gupta, Sachin, Iqbal, Ahmar, Kaner, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660106/ https://www.ncbi.nlm.nih.gov/pubmed/36376851 http://dx.doi.org/10.1186/s12890-022-02230-5 |
Ejemplares similares
-
Discriminatory Molecular Biomarkers of Allergic and Nonallergic Asthma and Its Severity
por: Baos, Selene, et al.
Publicado: (2019) -
Physiological signature of late-onset nonallergic asthma of obesity
por: Dixon, Anne E., et al.
Publicado: (2020) -
282 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation
por: Bergmann, Karl-Christian, et al.
Publicado: (2012) -
Data set on a study of gene expression in peripheral samples to identify biomarkers of severity of allergic and nonallergic asthma
por: Baos, Selene, et al.
Publicado: (2016) -
Nonallergic Asthma and Its Severity: Biomarkers for Its Discrimination in Peripheral Samples
por: Baos, Selene, et al.
Publicado: (2018)